Eris Lifesciences has issued a clarification regarding recent media reports and news articles covering its earlier disclosures.

The company has explicitly stated that investors must disregard incorrect figures circulating externally and rely solely on the accurate loan values provided in its official exchange filings.

This clarification ensures market transparency and guides stakeholders to make informed investment decisions based strictly on verified corporate disclosures rather than speculative or misreported media coverage.